<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Goldfarb DM</submitter><funding>British Columbia Children’s Hospital</funding><funding>Government of Canada: COVID-Immunity Task Force</funding><pagination>e057846</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8983418</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(4)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Few studies reported COVID-19 cases in schools during the 2020/21 academic year in a setting of uninterrupted in-person schooling. The main objective was to determine the SARS-CoV-2 seroprevalence among school staff in Vancouver public schools.&lt;h4>Design&lt;/h4>Cumulative incident COVID-19 cases among all students and school staff based on public health data, with an embedded cross-sectional serosurvey among a school staff sample that was compared to period, age, sex and geographical location-weighted data from blood donors.&lt;h4>Setting&lt;/h4>Vancouver School District (British Columbia, Canada) from kindergarten to grade 12.&lt;h4>Participants&lt;/h4>Active school staff enrolled from 3 February to 23 April 2021 with serology testing from 10 February to 15 May 2021.&lt;h4>Main outcome measures&lt;/h4>SARS-CoV-2 seroprevalence among school staff, based on spike (S)-based (unvaccinated staff) or N-based serology testing (vaccinated staff).&lt;h4>Results&lt;/h4>Public health data showed the cumulative incidence of COVID-19 among students attending in-person was 9.8 per 1000 students (n=47 280), and 13 per 1000 among school staff (n=7071). In a representative sample of 1689 school staff, 78.2% had classroom responsibilities, and spent a median of 17.6 hours in class per week (IQR: 5.0-25 hours). Although 21.5% (363/1686) of surveyed staff self-reported close contact with a COVID-19 case outside of their household (16.5% contacts were school-based), 5 cases likely acquired the infection at school based on viral testing. Sensitivity/Specificity-adjusted seroprevalence in 1556/1689 staff (92.1%) was 2.3% (95% CI: 1.6% to 3.2%), comparable to a sex, age, date and residency area-weighted seroprevalence of 2.6% (95% CI: 2.2% to 3.1%) among 5417 blood donors.&lt;h4>Conclusion&lt;/h4>Seroprevalence among staff was comparable to a reference group of blood donors from the same community. These data show that in-person schooling could be safely maintained during the 2020/21 school year with mitigation measures, in a large school district in Vancouver, Canada.</pubmed_abstract><journal>BMJ open</journal><pubmed_title>SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study.</pubmed_title><pmcid>PMC8983418</pmcid><funding_grant_id>AWD-016994 PHACA 2020</funding_grant_id><pubmed_authors>O'Reilly C</pubmed_authors><pubmed_authors>Watts AW</pubmed_authors><pubmed_authors>Choi A</pubmed_authors><pubmed_authors>Coombs D</pubmed_authors><pubmed_authors>Bosman ES</pubmed_authors><pubmed_authors>Xu RY</pubmed_authors><pubmed_authors>Hutchison SM</pubmed_authors><pubmed_authors>Sadarangani M</pubmed_authors><pubmed_authors>Razzaghian HR</pubmed_authors><pubmed_authors>Muttucomaroe L</pubmed_authors><pubmed_authors>O'Brien SF</pubmed_authors><pubmed_authors>Goldfarb DM</pubmed_authors><pubmed_authors>Masse LC</pubmed_authors><pubmed_authors>Lavoie PM</pubmed_authors><pubmed_authors>Irvine MA</pubmed_authors><pubmed_authors>Dhillon N</pubmed_authors><pubmed_authors>Sediqi S</pubmed_authors><pubmed_authors>Barakauskas VE</pubmed_authors><pubmed_authors>Reicherz F</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study.</name><description>&lt;h4>Objectives&lt;/h4>Few studies reported COVID-19 cases in schools during the 2020/21 academic year in a setting of uninterrupted in-person schooling. The main objective was to determine the SARS-CoV-2 seroprevalence among school staff in Vancouver public schools.&lt;h4>Design&lt;/h4>Cumulative incident COVID-19 cases among all students and school staff based on public health data, with an embedded cross-sectional serosurvey among a school staff sample that was compared to period, age, sex and geographical location-weighted data from blood donors.&lt;h4>Setting&lt;/h4>Vancouver School District (British Columbia, Canada) from kindergarten to grade 12.&lt;h4>Participants&lt;/h4>Active school staff enrolled from 3 February to 23 April 2021 with serology testing from 10 February to 15 May 2021.&lt;h4>Main outcome measures&lt;/h4>SARS-CoV-2 seroprevalence among school staff, based on spike (S)-based (unvaccinated staff) or N-based serology testing (vaccinated staff).&lt;h4>Results&lt;/h4>Public health data showed the cumulative incidence of COVID-19 among students attending in-person was 9.8 per 1000 students (n=47 280), and 13 per 1000 among school staff (n=7071). In a representative sample of 1689 school staff, 78.2% had classroom responsibilities, and spent a median of 17.6 hours in class per week (IQR: 5.0-25 hours). Although 21.5% (363/1686) of surveyed staff self-reported close contact with a COVID-19 case outside of their household (16.5% contacts were school-based), 5 cases likely acquired the infection at school based on viral testing. Sensitivity/Specificity-adjusted seroprevalence in 1556/1689 staff (92.1%) was 2.3% (95% CI: 1.6% to 3.2%), comparable to a sex, age, date and residency area-weighted seroprevalence of 2.6% (95% CI: 2.2% to 3.1%) among 5417 blood donors.&lt;h4>Conclusion&lt;/h4>Seroprevalence among staff was comparable to a reference group of blood donors from the same community. These data show that in-person schooling could be safely maintained during the 2020/21 school year with mitigation measures, in a large school district in Vancouver, Canada.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-26T05:42:38.924Z</modification><creation>2025-02-19T04:22:15.934Z</creation></dates><accession>S-EPMC8983418</accession><cross_references><pubmed>35383082</pubmed><doi>10.1136/bmjopen-2021-057846</doi></cross_references></HashMap>